Ardent Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Ardent Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$903K	Hold	15,675	–	–	0.38%	22
2026 Q1	$951K	Hold	15,675	–	–	0.41%	24
2025 Q4	$846K	Hold	15,675	–	–	0.33%	27
2025 Q3	$707K	Sell	15,675 -25	-0.2%	-$1.17K	0.3%	30
2025 Q2	$727K	Hold	15,700	–	–	0.35%	25
2025 Q1	$958K	Hold	15,700	–	–	0.41%	21
2024 Q4	$888K	Sell	15,700 -10,283	-40%	-$575K	0.4%	23
2024 Q3	$1.34M	Hold	25,983	–	–	0.61%	15
2024 Q2	$1.08M	Hold	25,983	–	–	0.53%	20
2024 Q1	$1.41M	Hold	25,983	–	–	0.71%	16
2023 Q4	$1.33M	Sell	25,983 -2,000	-7%	-$105K	0.7%	16
2023 Q3	$1.62M	Buy	+27,983	New	+$1.71M	0.92%	14
2023 Q1	–	Sell	-7,358	Closed	-$529K	–	30
2022 Q4	$529K	Buy	+7,358	New	+$555K	0.41%	16
2022 Q3	–	Sell	-5,108	Closed	-$393K	–	17
2022 Q2	$393K	Buy	5,108 +1,500	+42%	+$114K	0.48%	15
2022 Q1	$263K	Sell	3,608 -1,500	-29%	-$101K	0.18%	24
2021 Q4	$318K	Buy	+5,108	New	+$300K	0.21%	26

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Ardent Capital Management's BMY Position: Q2 2026 in Review

Ardent Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 15,675 shares worth $903K. The position accounts for 0.38% of the portfolio, ranked #22.

Ardent Capital Management first reported a position in BMY in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.62M in Q3 2023. 489 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Ardent Capital Management held 15,675 shares of Bristol-Myers Squibb worth $903K as of Q2 2026.
Ardent Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.38% of Ardent Capital Management's portfolio in Q2 2026, its #22 holding.
Ardent Capital Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 16 quarters since.
Ardent Capital Management's Bristol-Myers Squibb position peaked at $1.62M in Q3 2023.
489 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ardent Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.